Acarbose and Pulmonary oedema - a phase IV clinical study of FDA data

Summary:

Pulmonary oedema is reported as a side effect among people who take Acarbose (acarbose), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Furosemide, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Pulmonary oedema when taking Acarbose. It is created by eHealthMe based on reports of 4,551 people who have side effects when taking Acarbose from the FDA, and is updated regularly.

What is Acarbose?

Acarbose has active ingredients of acarbose. It is often used in diabetes. eHealthMe is studying from 4,605 Acarbose users. Check the latest studies of Acarbose.

What is Pulmonary oedema?

Pulmonary oedema (fluid accumulation in the lungs) is found to be associated with 1,848 drugs and 1,966 conditions by eHealthMe. Check the latest studies of Pulmonary oedema.

On Jul, 12, 2026

4,551 people reported to have side effects when taking Acarbose.
Among them, 19 people (0.42%) have Pulmonary oedema.

Among these 19 people:

How long have people been on Acarbose when they have Pulmonary oedema? *

What is the gender of people who have Pulmonary oedema when taking Acarbose? *

female: 50 %
male: 50 %

What is the age of people who have Pulmonary oedema when taking Acarbose? *

What are other drugs people take besides Acarbose? *

What are other side effects people have besides Pulmonary oedema? *

Acute Kidney Failure: 3 people, 15.79%
Urinary Tract Infection: 3 people, 15.79%
Blood Pressure Systolic Decreased: 2 people, 10.53%
Fever: 2 people, 10.53%
Hyperkalemia (damage to or disease of the kidney): 2 people, 10.53%
Chronic Renal Failure (kidney failure): 2 people, 10.53%
Cardiac Failure: 2 people, 10.53%
Bone Pain: 2 people, 10.53%
Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 2 people, 10.53%
Pneumonia: 2 people, 10.53%

What are the existing conditions these people have? *

Type 2 Diabetes: 4 people, 21.05%
Multiple Myeloma (cancer of the plasma cells): 3 people, 15.79%
Enlarged Prostate: 3 people, 15.79%
High Blood Pressure: 2 people, 10.53%
General Anaesthesia: 2 people, 10.53%
Anaesthesia: 2 people, 10.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 5.26%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 1 person, 5.26%
Nerve Block (the interruption of signals travelling along a nerve): 1 person, 5.26%
Irritability: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Acarbose and have Pulmonary oedema?

- Check whether Pulmonary oedema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Acarbose:

Acarbose (4,605 reports)

Pulmonary oedema treatments and more:

Pulmonary oedema (53,624 reports)

Browse all side effects of Acarbose:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Pulmonary oedema:

Pulmonary oedema (1,848 drugs)

Browse all the conditions that are associated with Pulmonary oedema:

Pulmonary oedema (1,966 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on acarbose (the active ingredients of Acarbose) and Acarbose (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.